Is Aligos Therapeutics, Inc. (ALGS) a Buy, Sell, or Hold?
Aligos Therapeutics, Inc.
NASDAQ:ALGS
$5.77 USD
-$0.34 (-5.49%)
- Volume
- 62.25K
- Average Volume
- 294.04K
- Market Capitalization
- $35.71M
- P/E Ratio
- -0.66
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $13.69
- Year Low
- $4.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.56
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
15
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
0
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ -
ALGS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ALGS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Preston Heather | director | 2026-06-25 | A-Award | 5.5 | 2026-06-29 |
| Chavez Margarita | director | 2026-06-25 | A-Award | 5.5 | 2026-06-29 |
| Martell Bridget A | director | 2026-06-25 | A-Award | 5.5 | 2026-06-29 |
| Scopa James Paul | director | 2026-06-25 | A-Award | 5.5 | 2026-06-29 |
| Nuechterlein Carole | director | 2026-06-25 | A-Award | 5.5 | 2026-06-29 |
| Hirth Peter | director | 2026-06-25 | A-Award | 5.5 | 2026-06-29 |
| Aneja Nikhil | officer: Principal Accounting Officer | 2026-03-09 | A-Award | 7.03 | 2026-03-11 |
| Calhoun Lesley Ann | officer: See Remarks | 2026-03-09 | A-Award | 7.03 | 2026-03-11 |
| BLATT LAWRENCE | director, officer: President and CEO | 2026-03-09 | A-Award | 7.03 | 2026-03-11 |
| Aneja Nikhil | officer: Principal Accounting Officer | 2026-01-29 | 16 | 2026-02-19 | |
| Aneja Nikhil | officer: Principal Accounting Officer | 2026-01-29 | 11.74 | 2026-02-19 | |
| Aneja Nikhil | officer: Principal Accounting Officer | 2026-01-29 | 16.87 | 2026-02-19 | |
| Aneja Nikhil | officer: Principal Accounting Officer | 2026-01-29 | 8.68 | 2026-02-19 | |
| BLATT LAWRENCE | director, officer: President and CEO | 2025-07-16 | A-Award | 8.68 | 2025-07-18 |
| Symons Julian A. | officer: See Remarks | 2025-07-16 | A-Award | 8.68 | 2025-07-18 |
| Calhoun Lesley Ann | officer: See Remarks | 2025-07-16 | A-Award | 8.68 | 2025-07-18 |
| Nuechterlein Carole | director | 2025-06-25 | A-Award | 7.63 | 2025-06-26 |
| Scopa James Paul | director | 2025-06-25 | A-Award | 7.63 | 2025-06-26 |
| Hirth Peter | director | 2025-06-25 | A-Award | 7.63 | 2025-06-26 |
| Preston Heather | director | 2025-06-25 | A-Award | 7.63 | 2025-06-26 |
| Chavez Margarita | director | 2025-06-25 | A-Award | 7.63 | 2025-06-26 |
| Martell Bridget A | director | 2025-06-25 | A-Award | 7.63 | 2025-06-26 |
| BLATT LAWRENCE | director, officer: President and CEO | 2025-02-28 | A-Award | 16.87 | 2025-03-04 |
| Symons Julian A. | officer: See Remarks | 2025-02-28 | A-Award | 16.87 | 2025-03-04 |
| Calhoun Lesley Ann | officer: See Remarks | 2025-02-28 | A-Award | 16.87 | 2025-03-04 |
| Achneck Hardean | officer: Chief Medical Officer | 2024-10-08 | A-Award | 7.32 | 2024-10-10 |
| Achneck Hardean | 2024-09-23 | 0 | 2024-09-26 | ||
| Calhoun Lesley Ann | other: See Remarks | 2024-09-04 | A-Award | 11.74 | 2024-09-06 |
| BLATT LAWRENCE | director, officer: Chief Executive Officer | 2024-09-04 | A-Award | 11.74 | 2024-09-06 |
| Symons Julian A. | officer: See Remarks | 2024-09-04 | A-Award | 11.74 | 2024-09-06 |
| Chavez Margarita | director | 2024-08-07 | A-Award | 0.55 | 2024-08-09 |
| Preston Heather | director | 2024-08-07 | A-Award | 0.55 | 2024-08-09 |
| Chavez Margarita | 2024-08-07 | 0 | 2024-08-09 | ||
| Preston Heather | 2024-08-07 | 0 | 2024-08-09 | ||
| Hirth Peter | director | 2024-06-27 | A-Award | 0.38 | 2024-06-28 |
| Nuechterlein Carole | director | 2024-06-27 | A-Award | 0.38 | 2024-06-28 |
| Scopa James Paul | director | 2024-06-27 | A-Award | 0.38 | 2024-06-28 |
| Martell Bridget A | director | 2024-06-27 | A-Award | 0.38 | 2024-06-28 |
| McClure Matthew W. | officer: Chief Medical Officer | 2024-03-01 | A-Award | 1.13 | 2024-03-04 |
| Calhoun Lesley Ann | other: See Remarks | 2024-03-01 | A-Award | 1.13 | 2024-03-04 |
| Symons Julian A. | officer: See Remarks | 2024-03-01 | A-Award | 1.13 | 2024-03-04 |
| BLATT LAWRENCE | director, officer: Chief Executive Officer | 2024-03-01 | A-Award | 1.13 | 2024-03-04 |
| Hirth Peter | director | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Hirth Peter | director | 2024-02-27 | D-Return | 26.58 | 2024-02-28 |
| Scopa James Paul | director | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Scopa James Paul | director | 2024-02-27 | D-Return | 29.1 | 2024-02-28 |
| McClure Matthew W. | officer: Chief Medical Officer | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| McClure Matthew W. | officer: Chief Medical Officer | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| McClure Matthew W. | officer: Chief Medical Officer | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| McClure Matthew W. | officer: Chief Medical Officer | 2024-02-27 | D-Return | 3.06 | 2024-02-28 |
| McClure Matthew W. | officer: Chief Medical Officer | 2024-02-27 | D-Return | 16.18 | 2024-02-28 |
| Calhoun Lesley Ann | other: See Remarks | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Calhoun Lesley Ann | other: See Remarks | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Calhoun Lesley Ann | other: See Remarks | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Calhoun Lesley Ann | other: See Remarks | 2024-02-27 | D-Return | 16.18 | 2024-02-28 |
| Calhoun Lesley Ann | other: See Remarks | 2024-02-27 | D-Return | 3.06 | 2024-02-28 |
| BLATT LAWRENCE | director, officer: Chief Executive Officer | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| BLATT LAWRENCE | director, officer: Chief Executive Officer | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| BLATT LAWRENCE | director, officer: Chief Executive Officer | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| BLATT LAWRENCE | director, officer: Chief Executive Officer | 2024-02-27 | D-Return | 3.06 | 2024-02-28 |
| BLATT LAWRENCE | director, officer: Chief Executive Officer | 2024-02-27 | D-Return | 16.18 | 2024-02-28 |
| Symons Julian A. | officer: See Remarks | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Symons Julian A. | officer: See Remarks | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Symons Julian A. | officer: See Remarks | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Symons Julian A. | officer: See Remarks | 2024-02-27 | D-Return | 3.06 | 2024-02-28 |
| Symons Julian A. | officer: See Remarks | 2024-02-27 | D-Return | 16.18 | 2024-02-28 |
| Nielsen Jack | director | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Nielsen Jack | director | 2024-02-27 | D-Return | 26.58 | 2024-02-28 |
| Nuechterlein Carole | director | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Nuechterlein Carole | director | 2024-02-27 | D-Return | 26.58 | 2024-02-28 |
| Martell Bridget A | director | 2024-02-28 | A-Award | 0.96 | 2024-02-28 |
| Martell Bridget A | director | 2024-02-27 | D-Return | 16.52 | 2024-02-28 |
| ROCHE HOLDING LTD | 10 percent owner | 2023-10-25 | 0 | 2023-11-07 | |
| ROCHE HOLDING LTD | 10 percent owner | 2023-10-25 | 0.7568 | 2023-11-07 | |
| Nuechterlein Carole | director, 10 percent owner: | 2023-10-25 | P-Purchase | 0.7568 | 2023-10-27 |
| Nuechterlein Carole | director, 10 percent owner: | 2023-10-25 | P-Purchase | 0.7568 | 2023-10-27 |
| BLATT LAWRENCE | director, officer: Chief Executive Officer | 2023-10-25 | A-Award | 0.7568 | 2023-10-27 |
| BLATT LAWRENCE | director, officer: Chief Executive Officer | 2023-10-25 | A-Award | 0.7568 | 2023-10-27 |
| Scopa James Paul | director | 2023-10-25 | A-Award | 0.7568 | 2023-10-27 |
| Scopa James Paul | director | 2023-10-25 | A-Award | 0.7568 | 2023-10-27 |
| McClure Matthew W. | officer: Chief Medical Officer | 2023-09-08 | A-Award | 0.84 | 2023-09-12 |
| Calhoun Lesley Ann | 2023-09-08 | A-Award | 0.84 | 2023-09-12 | |
| Quan Lucinda Y. | officer: See Remarks | 2023-09-08 | A-Award | 0.84 | 2023-09-12 |
| Symons Julian A. | officer: See Remarks | 2023-09-08 | A-Award | 0.84 | 2023-09-12 |
| BLATT LAWRENCE | officer: Chief Executive Officer | 2023-09-08 | A-Award | 0.84 | 2023-09-12 |
| Martell Bridget A | director | 2023-07-20 | A-Award | 1 | 2023-07-21 |
| Nielsen Jack | director | 2023-07-20 | A-Award | 1 | 2023-07-21 |
| Hirth Peter | director | 2023-07-20 | A-Award | 1 | 2023-07-21 |
| Scopa James Paul | director | 2023-07-20 | A-Award | 1 | 2023-07-21 |
| Nuechterlein Carole | director | 2023-07-20 | A-Award | 1 | 2023-07-21 |
| McClure Matthew W. | officer: Chief Medical Officer | 2023-03-15 | A-Award | 1.34 | 2023-03-17 |
| Symons Julian A. | officer: See Remarks | 2023-03-15 | A-Award | 1.34 | 2023-03-17 |
| Calhoun Lesley Ann | 2023-03-15 | A-Award | 1.34 | 2023-03-17 | |
| Quan Lucinda Y. | officer: See Remarks | 2023-03-15 | A-Award | 1.34 | 2023-03-17 |
| Beigelman Leonid | director, officer: President | 2023-03-15 | A-Award | 1.34 | 2023-03-17 |
| BLATT LAWRENCE | officer: Chief Executive Officer | 2023-03-15 | A-Award | 1.34 | 2023-03-17 |
| McClure Matthew W. | officer: Chief Medical Officer | 2022-07-07 | A-Award | 0 | 2022-07-11 |
| Quan Lucinda Y. | officer: See Remarks | 2022-07-07 | A-Award | 0 | 2022-07-11 |
| Quan Lucinda Y. | officer: See Remarks | 2022-07-07 | A-Award | 1.41 | 2022-07-11 |
| Calhoun Lesley Ann | other: See Remarks | 2022-07-07 | A-Award | 1.41 | 2022-07-11 |